A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Takeda
Related studies linked through entity extraction aliases.
A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954
- Status
- COMPLETED
- Phase
- PHASE1
Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954
- Status
- COMPLETED
- Phase
- PHASE1
Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training
- Status
- COMPLETED
- Phase
- PHASE4
Single Ascending Dose Study of MEDI1341 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302
- Status
- COMPLETED
- Phase
- PHASE3
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement
- Status
- COMPLETED
- Phase
- NA
An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis
- Status
- WITHDRAWN
- Phase
- PHASE4
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.
- Status
- COMPLETED
- Phase
- PHASE3
Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"
- Status
- COMPLETED
- Phase
- N/A